179 related articles for article (PubMed ID: 36631279)
1. Initial Pharmacological Characterization of a Major Hydroxy Metabolite of PF-5190457: Inverse Agonist Activity of PF-6870961 at the Ghrelin Receptor.
Deschaine SL; Hedegaard MA; Pince CL; Farokhnia M; Moose JE; Stock IA; Adusumalli S; Akhlaghi F; Hougland JL; Sulima A; Rice KC; Koob GF; Vendruscolo LF; Holst B; Leggio L
J Pharmacol Exp Ther; 2023 Aug; 386(2):117-128. PubMed ID: 36631279
[TBL] [Abstract][Full Text] [Related]
2. A Novel Truncated Liver Enriched Antimicrobial Peptide-2 Palmitoylated at its N-Terminal Antagonizes Effects of Ghrelin.
Holá L; Železná B; Karnošová A; Kuneš J; Fehrentz JA; Denoyelle S; Cantel S; Blechová M; Sýkora D; Myšková A; Maletínská L
J Pharmacol Exp Ther; 2022 Nov; 383(2):129-136. PubMed ID: 36198495
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological characterization of the first in class clinical candidate PF-05190457: a selective ghrelin receptor competitive antagonist with inverse agonism that increases vagal afferent firing and glucose-dependent insulin secretion ex vivo.
Kong J; Chuddy J; Stock IA; Loria PM; Straub SV; Vage C; Cameron KO; Bhattacharya SK; Lapham K; McClure KF; Zhang Y; Jackson VM
Br J Pharmacol; 2016 May; 173(9):1452-64. PubMed ID: 26784385
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of PF-6870961, a major hydroxy metabolite of the novel ghrelin receptor inverse agonist PF-5190457.
Sulima A; Akhlaghi F; Leggio L; Rice KC
Bioorg Med Chem; 2021 Nov; 50():116465. PubMed ID: 34662828
[TBL] [Abstract][Full Text] [Related]
5. The novel ghrelin receptor inverse agonist PF-5190457 administered with alcohol: preclinical safety experiments and a phase 1b human laboratory study.
Lee MR; Tapocik JD; Ghareeb M; Schwandt ML; Dias AA; Le AN; Cobbina E; Farinelli LA; Bouhlal S; Farokhnia M; Heilig M; Akhlaghi F; Leggio L
Mol Psychiatry; 2020 Feb; 25(2):461-475. PubMed ID: 29728704
[TBL] [Abstract][Full Text] [Related]
6. Endocrine effects of the novel ghrelin receptor inverse agonist PF-5190457: Results from a placebo-controlled human laboratory alcohol co-administration study in heavy drinkers.
Lee MR; Farokhnia M; Cobbina E; Saravanakumar A; Li X; Battista JT; Farinelli LA; Akhlaghi F; Leggio L
Neuropharmacology; 2020 Jun; 170():107788. PubMed ID: 31557492
[TBL] [Abstract][Full Text] [Related]
7. Differential functional selectivity and downstream signaling bias of ghrelin receptor antagonists and inverse agonists.
Ramirez VT; van Oeffelen WEPA; Torres-Fuentes C; Chruścicka B; Druelle C; Golubeva AV; van de Wouw M; Dinan TG; Cryan JF; Schellekens H
FASEB J; 2019 Jan; 33(1):518-531. PubMed ID: 30020830
[TBL] [Abstract][Full Text] [Related]
8. Lentivirus-mediated shRNA interference of ghrelin receptor blocks proliferation in the colorectal cancer cells.
Liu A; Huang C; Xu J; Cai X
Cancer Med; 2016 Sep; 5(9):2417-26. PubMed ID: 27464938
[TBL] [Abstract][Full Text] [Related]
9. Ghrelin receptor activity amplifies hippocampal N-methyl-d-aspartate receptor-mediated postsynaptic currents and increases phosphorylation of the GluN1 subunit at Ser896 and Ser897.
Muniz BG; Isokawa M
Eur J Neurosci; 2015 Dec; 42(12):3045-53. PubMed ID: 26490687
[TBL] [Abstract][Full Text] [Related]
10. N-Terminal Liver-Expressed Antimicrobial Peptide 2 (LEAP2) Region Exhibits Inverse Agonist Activity toward the Ghrelin Receptor.
M'Kadmi C; Cabral A; Barrile F; Giribaldi J; Cantel S; Damian M; Mary S; Denoyelle S; Dutertre S; Péraldi-Roux S; Neasta J; Oiry C; Banères JL; Marie J; Perello M; Fehrentz JA
J Med Chem; 2019 Jan; 62(2):965-973. PubMed ID: 30543423
[TBL] [Abstract][Full Text] [Related]
11. Sites of action of ghrelin receptor ligands in cardiovascular control.
Callaghan B; Hunne B; Hirayama H; Sartor DM; Nguyen TV; Abogadie FC; Ferens D; McIntyre P; Ban K; Baell J; Furness JB; Brock JA
Am J Physiol Heart Circ Physiol; 2012 Oct; 303(8):H1011-21. PubMed ID: 22886413
[TBL] [Abstract][Full Text] [Related]
12. G Protein and β-arrestin signaling bias at the ghrelin receptor.
Evron T; Peterson SM; Urs NM; Bai Y; Rochelle LK; Caron MG; Barak LS
J Biol Chem; 2014 Nov; 289(48):33442-55. PubMed ID: 25261469
[TBL] [Abstract][Full Text] [Related]
13. Role of Molybdenum-Containing Enzymes in the Biotransformation of the Novel Ghrelin Receptor Inverse Agonist PF-5190457: A Reverse Translational Bed-to-Bench Approach.
Adusumalli S; Jamwal R; Obach RS; Ryder TF; Leggio L; Akhlaghi F
Drug Metab Dispos; 2019 Aug; 47(8):874-882. PubMed ID: 31182423
[TBL] [Abstract][Full Text] [Related]
14. MRAP2 inhibits β-arrestin recruitment to the ghrelin receptor by preventing GHSR1a phosphorylation.
Rouault AAJ; Buscaglia P; Sebag JA
J Biol Chem; 2022 Jun; 298(6):102057. PubMed ID: 35605660
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological GHSR (ghrelin receptor) blockade reduces alcohol binge-like drinking in male and female mice.
Richardson RS; Sulima A; Rice KC; Kucharczk JA; Janda KD; Nisbett KE; Koob GF; Vendruscolo LF; Leggio L
Neuropharmacology; 2023 Nov; 238():109643. PubMed ID: 37369277
[TBL] [Abstract][Full Text] [Related]
16. Ghrelin receptor inverse agonists as a novel therapeutic approach against obesity-related metabolic disease.
Abegg K; Bernasconi L; Hutter M; Whiting L; Pietra C; Giuliano C; Lutz TA; Riediger T
Diabetes Obes Metab; 2017 Dec; 19(12):1740-1750. PubMed ID: 28544245
[TBL] [Abstract][Full Text] [Related]
17. Z-505 hydrochloride ameliorates chemotherapy-induced anorexia in rodents via activation of the ghrelin receptor, GHSR1a.
Shiomi Y; Ohira Y; Yoshimura M; Ozaki T; Takei M; Tanaka T
Eur J Pharmacol; 2018 Jan; 818():148-157. PubMed ID: 29066414
[TBL] [Abstract][Full Text] [Related]
18. GSK1614343, a novel ghrelin receptor antagonist, produces an unexpected increase of food intake and body weight in rodents and dogs.
Costantini VJ; Vicentini E; Sabbatini FM; Valerio E; Lepore S; Tessari M; Sartori M; Michielin F; Melotto S; Bifone A; Pich EM; Corsi M
Neuroendocrinology; 2011; 94(2):158-68. PubMed ID: 21778696
[TBL] [Abstract][Full Text] [Related]
19. G protein-coupled receptor interactions and modification of signalling involving the ghrelin receptor, GHSR1a.
Ringuet MT; Furness JB; Furness SGB
J Neuroendocrinol; 2022 Sep; 34(9):e13077. PubMed ID: 34931385
[TBL] [Abstract][Full Text] [Related]
20. Establishment of a Cell Line Stably Expressing the Growth Hormone Secretagogue Receptor to Identify Crocin as a Ghrelin Agonist.
Wang CH; Tseng CY; Hsu WL; Tzen JTC
Biomolecules; 2022 Dec; 12(12):. PubMed ID: 36551241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
